IL10 and keloid: To investigate the potential of IL‐10 delivery via ADSCs to promote myofibroblast regression in vitro, we evaluated the changes in α‐smooth muscle actin (α‐SMA) and TGF‐β1 expression in human keloid‐derived fibroblasts.